Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angion Biomedica Corp (NQ: ANGN )

1.500 +0.180 (+13.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 199,965
Open 1.320
Bid (Size) 1.150 (40)
Ask (Size) 1.600 (10)
Prev. Close 1.320
Today's Range 1.310 - 1.560
52wk Range 1.075 - 16.04
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Angion Biomedica: Q1 Earnings Insights
Angion Biomedica (NASDAQ:ANGN) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Angion Biomedica Is 'Better Positioned' Than Peers Despite Trial Failure, HC Wainwright Thinks So
 
Via Benzinga

Performance

YTD
-48.63%
-48.63%
1 Month
+17.19%
+17.19%
3 Month
-19.35%
-19.35%
6 Month
-58.33%
-58.33%
1 Year
-90.28%
-90.28%

More News

Read More
Angion Biomedica's Return On Capital Employed Insights
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
52 Biggest Movers From Friday
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 150 Points; SigmaTron International Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
63 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
50 Biggest Movers From Friday
Via Benzinga
Mid-Day Market Update: Oracle Gains Following Upbeat Q2 Results; Angion Biomedica Shares Drop
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Morning Market Update: Markets Open Higher; Inflation Rate Increases To 6.8%
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
Via Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
Via Benzinga
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
From Vifor Pharma
Via Business Wire
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
64 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Did Angion Biomedica's Shares tumble Premarket Today?
Via Benzinga
Exposures COVID-19
28 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.